Ani Pharmaceuticals (ANIP) Total Non-Current Liabilities (2015 - 2026)
Ani Pharmaceuticals (ANIP) posted Total Non-Current Liabilities of $881.37 million for Q2 2026, down 0.8% from $888.16 million a year earlier but up 4.5% from the prior quarter.
Powered by 
Analysis
Ani Pharmaceuticals (ANIP) Total Non-Current Liabilities (2015 - 2026) Analysis & Trends
At the end of FY2025, Ani Pharmaceuticals' Total Non-Current Liabilities came in at $887.49 million, up 3.1% from FY2024.
- Annual Total Non-Current Liabilities has increased for seven consecutive years, with a five-year compound annual growth rate of 28.7% (FY2020 to FY2025).
- In prior years, Ani Pharmaceuticals' Total Non-Current Liabilities was $860.96 million in FY2024 (+92.3%), $447.67 million in FY2023 (+8.8%), $411.34 million in FY2022 (+1.1%) and $406.71 million in FY2021 (+62.0%).
- Quarterly Total Non-Current Liabilities has run from a low of $270.94 million in Q3 2021 to a high of $890.96 million in Q3 2025 over five years.
- On a year-over-year basis, Total Non-Current Liabilities increased in six of the last eight quarters, with growth averaging 46.8%.
- The strongest year-over-year quarter for Total Non-Current Liabilities in the past five years was Q2 2025, with growth of 96.0%; the weakest was Q1 2026, with a decline of 1.5%.
- According to Business Quant data, Total Non-Current Liabilities for the three prior quarters was $843.22 million (Q1 2026), $887.49 million (Q4 2025) and $890.96 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Non-Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 105.99 Bn |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 106.45 Bn |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 80.25 Bn |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | 48.34 Bn |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | -967.00 Mn |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 81.11 Bn |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | 36.04 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 100.86 Bn |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 5.92 Bn |
| 10 | Ani Pharmaceuticals | 1.73 Bn | 512.62 Mn | 165.89 Mn | 881.37 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 881.37 Mn |
| Mar 31, 2026 | 843.22 Mn |
| Dec 31, 2025 | 887.49 Mn |
| Sep 30, 2025 | 890.96 Mn |
| Jun 30, 2025 | 888.16 Mn |
| Mar 31, 2025 | 856.38 Mn |
| Dec 31, 2024 | 860.96 Mn |
| Sep 30, 2024 | 861.25 Mn |
| Jun 30, 2024 | 453.09 Mn |
| Mar 31, 2024 | 450.96 Mn |
| Dec 31, 2023 | 447.67 Mn |
| Sep 30, 2023 | 449.49 Mn |
| Jun 30, 2023 | 437.69 Mn |
| Mar 31, 2023 | 437.33 Mn |
| Dec 31, 2022 | 411.34 Mn |
| Sep 30, 2022 | 393.85 Mn |
| Jun 30, 2022 | 408.27 Mn |
| Mar 31, 2022 | 391.55 Mn |
| Dec 31, 2021 | 406.71 Mn |
| Sep 30, 2021 | 270.94 Mn |
API Access
Ani Pharmaceuticals Total Non-Current Liabilities API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "total-non-current-liabilities", "ticker": "ANIP", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=total-non-current-liabilities&ticker=ANIP&period=max&api_key=YOUR_API_KEY");
const data = await res.json();